These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Secretase inhibitors and modulators for Alzheimer's disease treatment. Tomita T Expert Rev Neurother; 2009 May; 9(5):661-79. PubMed ID: 19402777 [TBL] [Abstract][Full Text] [Related]
4. [beta-amyloid cascade: current status and future directions]. Iwatsubo T Rinsho Shinkeigaku; 2000 Dec; 40(12):1228-30. PubMed ID: 11464463 [TBL] [Abstract][Full Text] [Related]
5. [Therapy of Alzheimer disease]. Kovács T Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816 [TBL] [Abstract][Full Text] [Related]
6. [Amyloid-beta 42 generating process may have a biological role in regulation of Notch signaling intensity]. Tagami S; Okochi M; Fukumori A; Takeda M Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Nov; 28(5-6):177-83. PubMed ID: 19108503 [TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease and Notch signaling. Woo HN; Park JS; Gwon AR; Arumugam TV; Jo DG Biochem Biophys Res Commun; 2009 Dec; 390(4):1093-7. PubMed ID: 19853579 [TBL] [Abstract][Full Text] [Related]
8. Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease. Martone RL; Zhou H; Atchison K; Comery T; Xu JZ; Huang X; Gong X; Jin M; Kreft A; Harrison B; Mayer SC; Aschmies S; Gonzales C; Zaleska MM; Riddell DR; Wagner E; Lu P; Sun SC; Sonnenberg-Reines J; Oganesian A; Adkins K; Leach MW; Clarke DW; Huryn D; Abou-Gharbia M; Magolda R; Bard J; Frick G; Raje S; Forlow SB; Balliet C; Burczynski ME; Reinhart PH; Wan HI; Pangalos MN; Jacobsen JS J Pharmacol Exp Ther; 2009 Nov; 331(2):598-608. PubMed ID: 19671883 [TBL] [Abstract][Full Text] [Related]
9. Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) as a biological candidate marker of Alzheimer's disease. Hampel H; Shen Y Scand J Clin Lab Invest; 2009; 69(1):8-12. PubMed ID: 18609117 [TBL] [Abstract][Full Text] [Related]
10. Pathological activity of familial Alzheimer's disease-associated mutant presenilin can be executed by six different gamma-secretase complexes. Shirotani K; Tomioka M; Kremmer E; Haass C; Steiner H Neurobiol Dis; 2007 Jul; 27(1):102-7. PubMed ID: 17560791 [TBL] [Abstract][Full Text] [Related]
11. Advances in gamma-secretase modulation. Pissarnitski D Curr Opin Drug Discov Devel; 2007 Jul; 10(4):392-402. PubMed ID: 17659480 [TBL] [Abstract][Full Text] [Related]
12. The structure and function of Alzheimer's gamma secretase enzyme complex. Krishnaswamy S; Verdile G; Groth D; Kanyenda L; Martins RN Crit Rev Clin Lab Sci; 2009; 46(5-6):282-301. PubMed ID: 19958215 [TBL] [Abstract][Full Text] [Related]
18. The proteins BACE1 and BACE2 and beta-secretase activity in normal and Alzheimer's disease brain. Stockley JH; O'Neill C Biochem Soc Trans; 2007 Jun; 35(Pt 3):574-6. PubMed ID: 17511655 [TBL] [Abstract][Full Text] [Related]
19. Regulation of gamma-secretase activity in Alzheimer's disease. Zhou S; Zhou H; Walian PJ; Jap BK Biochemistry; 2007 Mar; 46(10):2553-63. PubMed ID: 17298085 [TBL] [Abstract][Full Text] [Related]
20. (S)-N-(5-Chlorothiophene-2-sulfonyl)-beta,beta-diethylalaninol a Notch-1-sparing gamma-secretase inhibitor. Cole DC; Stock JR; Kreft AF; Antane M; Aschmies SH; Atchison KP; Casebier DS; Comery TA; Diamantidis G; Ellingboe JW; Harrison BL; Hu Y; Jin M; Kubrak DM; Lu P; Mann CW; Martone RL; Moore WJ; Oganesian A; Riddell DR; Sonnenberg-Reines J; Sun SC; Wagner E; Wang Z; Woller KR; Xu Z; Zhou H; Jacobsen JS Bioorg Med Chem Lett; 2009 Feb; 19(3):926-9. PubMed ID: 19097890 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]